Kevin Mannix | SVP, IR |
Kare Schultz | President, CEO & Director |
Eli Kalif | EVP & CFO |
Brendan O'Grady | EVP, North America Commercial |
Gregory Gilbert | Truist Securities |
Umer Raffat | Evercore ISI |
Aaron Gal | Sanford C. Bernstein & Co. |
Lucas Lee | Raymond James & Associates |
Akash Tewari | Wolfe Research |
David Amsellem | Piper Sandler & Co. |
Randall Stanicky | RBC Capital Markets |
Ladies and gentlemen, thank you for standing by, and welcome to the Teva Pharmaceutical Third Quarter 2020 Earnings Call. [Operator Instructions]. And I would now like to hand the conference over to your first speaker, Kevin Mannix, Senior Vice President, Investor Relations. Please go ahead, sir.
Thank you, Valerie, and thank you, everyone, for joining us today to discuss Teva's third quarter 2020 financial results.